Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
or

Longboard Pharmaceuticals Inc (LBPH)

Longboard Pharmaceuticals Inc (LBPH)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
59.98 +0.02 (+0.03%) 11/29/24 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 59.98 unch (unch) -
Quote Overview for Fri, Nov 29th, 2024
Day Low
59.98
Day High
60.03
Open 59.99
Previous Close 59.96 59.96
Volume 655,700 655,700
Avg Vol 866,510 866,510
Stochastic %K 94.39% 94.39%
Weighted Alpha +188.68 +188.68
5-Day Change +0.21 (+0.35%) +0.21 (+0.35%)
52-Week Range 3.60 - 60.03 3.60 - 60.03
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,341,979
  • Shares Outstanding, K 39,046
  • Annual Sales, $ 0 K
  • Annual Income, $ -54,420 K
  • EBIT $ -87 M
  • EBITDA $ -87 M
  • 60-Month Beta 1.07
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 8.51
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.23
  • Most Recent Earnings $-0.63 on 11/07/24
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.64
  • Number of Estimates 4
  • High Estimate -0.62
  • Low Estimate -0.65
  • Prior Year -0.62
  • Growth Rate Est. (year over year) -3.23%

Price Performance

See More
Period Period Low Period High Performance
1-Month
58.82 +1.97%
on 11/04/24
Period Open: 59.57
60.03 -0.08%
on 11/29/24
+0.41 (+0.69%)
since 10/29/24
3-Month
27.35 +119.31%
on 09/17/24
Period Open: 35.54
60.03 -0.08%
on 11/29/24
+24.44 (+68.77%)
since 08/29/24
52-Week
3.60 +1,566.11%
on 11/30/23
Period Open: 3.68
60.03 -0.08%
on 11/29/24
+56.30 (+1,529.89%)
since 11/29/23

Most Recent Stories

More News
S&P 500 and Dow Jones Industrials Post Record Highs on Earnings Optimism

The S&P 500 Index ($SPX ) (SPY ) Monday closed up by +0.77%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up by +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up by +0.82%. Stocks rallied...

AMAT : 149.89 (-2.44%)
MPC : 149.89 (+0.54%)
AAPL : 221.95 (-0.80%)
MRO : 28.55 (-1.28%)
$IUXX : 19,948.80 (-1.67%)
LBPH : 59.98 (+0.03%)
AMGN : 306.58 (-0.09%)
ASML : 703.74 (-3.16%)
ZNM25 : 110-165 (-0.21%)
OXY : 49.85 (+1.71%)
VFC : 16.21 (-1.58%)
S : 19.85 (-1.64%)
Stocks Climb on Strength in Tech and Earnings Optimism

The S&P 500 Index ($SPX ) (SPY ) today is up by +0.60%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up by +0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up by +0.68%. Stocks today are climbing,...

MSTR : 325.62 (-4.74%)
GOOGL : 166.59 (-2.33%)
AMAT : 149.89 (-2.44%)
DE : 478.80 (-0.03%)
AAPL : 221.95 (-0.80%)
EXPD : 119.08 (+0.64%)
$IUXX : 19,948.80 (-1.67%)
LBPH : 59.98 (+0.03%)
AMGN : 306.58 (-0.09%)
COIN : 193.37 (-5.32%)
ASML : 703.74 (-3.16%)
ZNM25 : 110-165 (-0.21%)
S&P 500 Posts a Record High on Corporate Earnings Optimism

The S&P 500 Index ($SPX ) (SPY ) today is up by +0.60%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down by -0.15%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up by +1.00%. Stocks today are mostly...

MSTR : 325.62 (-4.74%)
AMAT : 149.89 (-2.44%)
APP : 325.49 (-6.01%)
AVGO : 178.74 (-5.06%)
$IUXX : 19,948.80 (-1.67%)
LBPH : 59.98 (+0.03%)
AMGN : 306.58 (-0.09%)
COIN : 193.37 (-5.32%)
ASML : 703.74 (-3.16%)
ZNM25 : 110-165 (-0.21%)
VFC : 16.21 (-1.58%)
S : 19.85 (-1.64%)
3 'Strong-Buy'-Rated Russell 2000 Stocks With 54% to 110% Upside

Investing in these small caps could be rewarding in the long run.

VKTX : 26.03 (-6.97%)
ARQT : 16.64 (-2.75%)
LBPH : 59.98 (+0.03%)
$SPX : 5,721.10 (-0.96%)
3 Russell 2000 Growth Stocks That Could Be Worth the Risk

These three small-cap stocks could deliver hefty returns if the central bank cuts rates.

LBPH : 59.98 (+0.03%)
RNA : 32.05 (-0.16%)
SOUN : 9.65 (-5.39%)
5 Breakout Biotech Stocks Leading the Russell 2000 Higher

These small-cap biotech stocks are rallying hard in 2024, and still have room to keep leading the RUT higher.

JANX : 30.12 (-2.30%)
VKTX : 26.03 (-6.97%)
LBPH : 59.98 (+0.03%)
ARQT : 16.64 (-2.75%)
RNA : 32.05 (-0.16%)
Forget the "Magnificent Seven" -- This Stock Has Nearly Quadrupled in 2024, and Wall Street Thinks It Can Go a Lot Higher

You might say that this biotech stock is magnificent.

META : 612.05 (-2.28%)
MSFT : 391.58 (-0.91%)
GOOGL : 166.59 (-2.33%)
AAPL : 221.95 (-0.80%)
TSLA : 270.83 (-6.01%)
AMZN : 201.68 (-1.96%)
NVDA : 113.47 (-5.98%)
GOOG : 168.84 (-2.29%)
LBPH : 59.98 (+0.03%)
Longboard Pharmaceuticals to Present at the 22nd Annual Needham Virtual Healthcare Conference

Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced that Brandi...

LBPH : 59.98 (+0.03%)
Longboard Pharmaceuticals Reports Full Year 2022 Financial Results and Key Corporate Initiatives

Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today provided a corporate update...

LBPH : 59.98 (+0.03%)
Longboard Pharmaceuticals to Report Full Year 2022 Financial Results and Key Corporate Initiatives on March 2, 2023

Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced that it plans...

LBPH : 59.98 (+0.03%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Longboard Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It focuses on developing novel, transformative medicines for neurological diseases. Longboard Pharmaceuticals Inc. is based in SAN DIEGO.

See More

Key Turning Points

3rd Resistance Point 60.06
2nd Resistance Point 60.05
1st Resistance Point 60.01
Last Price 59.98
1st Support Level 59.96
2nd Support Level 59.95
3rd Support Level 59.91

See More

52-Week High 60.03
Last Price 59.98
Fibonacci 61.8% 38.47
Fibonacci 50% 31.81
Fibonacci 38.2% 25.16
52-Week Low 3.60

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trading Volatility: How to Use IV Rank & Percentile for Smarter Options Strategies